Skip to main content

Advertisement

SpringerLink
Log in

Ovarian Reserve Test: An Impartial Means to Resolve the Mismatch Between Chronological and Biological Age in the Assessment of Female Reproductive Chances

  • Original Article
  • Published:
Reproductive Sciences Aims and scope Submit manuscript

Abstract

Nowadays, the ovarian reserve (OR) is considered more important than chronological age to estimate female reproductive capability. We conducted a retrospective, observational, and cohort study in order to detect the best predictor marker of OR, ovarian response, chances to obtain high-quality embryos, and pregnancy after in vitro fertilization (IVF) cycle in elderly women. For all eligible patients (aged between 40 and 50 and admitted to their first IVF cycle for primary infertility), we investigated the biochemical parameters and ultrasound aspects of ovaries and how they affected IVF outcomes. Age, basal follicle-stimulating hormone, basal luteinizing hormone, and basal-17β-estradiol are better related to the dose of gonadotropin used during a controlled ovarian stimulation cycle. Basal anti-Müllerian hormone (AMH), antral follicular count (AFC), and maximum serum level of 17β-estradiol before pickup resulted the best predictors of chances to retrieve at least 6 oocytes (at least 3 in metaphase II) and to have at least 1 to 3 embryos. The basal AMH, AFC and maximum serum level of 17β-estradiol before pickup continue to show higher correlation to pregnancy rate. The maximum endometrial thickness at pickup resulted important to predict the pregnancy rate and the chances to detect ongoing pregnancy. It seems mandatory to well define the ovarian biological age rather than the chronological one in women older than 40 years of age in order to give the best counseling and to choose the most appropriate IVF protocols.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Qiao J, Wang ZB, Feng HL, et al. The root of reduced fertility in aged women and possible therapeutic options: current status and future prospects [published online June 21, 2013.]. Mol Aspects Med. 2013.

  2. Repubblica Italiana—Bollettino Ufficiale—Regione del Veneto. Disposizioni in materia di attività di Procreazione Medicalmente Assistita (Pma), Venezia, Italy, venerdì 8 luglio 2011 Anno XLII, N. 49. http://bur.regione.veneto.it/BurvServices/pubblica/DettaglioDgr.aspx?id=233370. Accessed May 30, 2013.

  3. Gizzo S, Ancona E, Patrelli TS, et al. Fertility preservation in young women with cervical cancer: an oncologic dilemma or a new conception of fertility sparing surgery? Cancer Invest. 2013;31(3):189.

    Article  Google Scholar 

  4. te Velde ER, Pearson PL. The variability of female reproductive aging. Hum Reprod Update. 2002;8(2):141–154.

    Article  Google Scholar 

  5. Toner JP, Seifer DB. Why we may abandon basal follicle-stimulating hormone testing: a sea change in determining ovarian reserve using anti-Müllerian hormone. Fertil Steril. 2013;99(7):1825–1830.

    Article  CAS  Google Scholar 

  6. Practice Committee of the American Society for Reproductive Medicine. Testing and interpreting measures of ovarian reserve: a committee opinion. Fertil Steril. 2012;98(6):1407–1415.

    Article  Google Scholar 

  7. Kwok R, Johnson NP. Ovarian biopsy has no role as a routine diagnostic test of ovarian reserve: a systematic review. Reprod Biomed Online. 2012;24(5):492–495.

    Article  Google Scholar 

  8. Moolenaar LM, Broekmans FJ, van Disseldorp J, et al. Cost effectiveness of ovarian reserve testing in in vitro fertilization: a Markov decision-analytic model. Fertil Steril. 2011;96(4):889–894.

    Article  Google Scholar 

  9. La Marca A, Argento C, Sighinolfi G, et al. Possibilities and limits of ovarian reserve testing in ART. Curr Pharm Biotechnol. 2012;13(3):398–408.

    Article  Google Scholar 

  10. Patrelli TS, Gizzo S, Sianesi N, et al. Anti-Müllerian hormone serum values and ovarian reserve: can it predict a decrease in fertility after ovarian stimulation by ART cycles? PLoS One. 2012; 7(9):e44571.

    Article  CAS  Google Scholar 

  11. World Health Organization. WHO Laboratory Manual for the Examination of Human Semen and Sperm-Cervical Mucus Interaction. Cambridge, UK: Cambridge University Press; 1999.

    Google Scholar 

  12. Son WY, Chung JT, Henderson S, et al. Fertilization and embryo development with spermatozoa obtained from testicular sperm extraction into oocytes generated from human chorionic gonadotropin-primed in vitro maturation cycles [published online June 24, 2013]. Fertil Steril. 2013.

  13. Khoudja R, Li T, Ding C, et al. Effect of co-incubation of oocytes with a decreasing number of spermatozoa on embryo quality. Reprod Biomed Online. 2013;26(4):353–359.

    Article  Google Scholar 

  14. Broekmans FJ, Kwee J, Hendriks DJ, Mol BW, Lambalk CB. A systematic review of tests predicting ovarian reserve and IVF outcome. Hum Reprod Update. 2006;12(6):685–718.

    Article  CAS  Google Scholar 

  15. De Brucker M, Camus M, Haentjens P, Verheyen G, Collins J, Tournaye H. Assisted reproduction using donor spermatozoa in women aged 40 and above: the high road or the low road? Reprod Biomed Online. 2013;26(6):577–585.

    Article  Google Scholar 

  16. Hourvitz A, Machtinger R, Maman E, Baum M, Dor J, Levron J. Assisted reproduction in women over 40 years of age: how old is too old? Reprod Biomed Online. 2009;19(4):599–603.

    Article  Google Scholar 

  17. Keehn J, Holwell E, Abdul-Karim R, et al. Recruiting egg donors online: an analysis of in vitro fertilization clinic and agency websites’ adherence to American society for reproductive medicine guidelines. Fertil Steril. 2012;98(4):995–1000.

    Article  Google Scholar 

  18. Akande VA, Fleming CF, Hunt LP, Keay SD, Jenkins JM. Biological versus chronological ageing of oocytes, distinguishable by raised FSH levels in relation to the success of IVF treatment. Hum Reprod. 2002;17(8):2003–2008.

    Article  CAS  Google Scholar 

  19. Alviggi C, Humaidan P, Howles CM, Tredway D, Hillier SG. Biological versus chronological ovarian age: implications for assisted reproductive technology. Reprod Biol Endocrinol. 2009;7:101.

    Article  Google Scholar 

  20. Zhao J, Zhang Q, Li Y. The effect of endometrial thickness and pattern measured by ultrasonography on pregnancy outcomes during IVF-ET cycles. Reprod Biol Endocrinol. 2012;10:100.

    Article  Google Scholar 

  21. Zhang X, Chen CH, Confino E, Barnes R, Milad M, Kazer RR. Increased endometrial thickness is associated with improved treatment outcome for selected patients undergoing in vitro fertilization-embryo transfer. Fertil Steril. 2005;83(2):336–340.

    Article  Google Scholar 

  22. Kondapalli LA, Molinaro TA, Sammel MD, Dokras A. A decrease in serum estradiol levels after human chorionic gonadotrophin administration predicts significantly lower clinical pregnancy and live birth rates in in vitro fertilization cycles. Hum Reprod. 2012;27(9):2690–2697.

    Article  CAS  Google Scholar 

  23. Chen CH, Zhang X, Barnes R, et al. Relationship between peak serum estradiol levels and treatment outcome in in vitro fertilization cycles after embryo transfer on day 3 or day 5. Fertil Steril. 2003; 80(1):75–79.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Woman and Child Health, University of Padua, Padua, Italy

    Salvatore Gizzo MD, Alessandra Andrisani MD, PhD, Federica Esposito MD, Alessandra Oliva BS, Cecilia Zicchina BS, Denise Capuzzo MD, Michele Gangemi MD & Giovanni Battista Nardelli MD

Authors
  1. Salvatore Gizzo MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Alessandra Andrisani MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Federica Esposito MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Alessandra Oliva BS
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Cecilia Zicchina BS
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Denise Capuzzo MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Michele Gangemi MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Giovanni Battista Nardelli MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Salvatore Gizzo MD.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gizzo, S., Andrisani, A., Esposito, F. et al. Ovarian Reserve Test: An Impartial Means to Resolve the Mismatch Between Chronological and Biological Age in the Assessment of Female Reproductive Chances. Reprod. Sci. 21, 632–639 (2014). https://doi.org/10.1177/1933719113508821

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1177/1933719113508821

Keywords

Search

Navigation